Loading...

We've got a brand new version of Simply Wall St! Try it out

Corpovael. de

DB:CPL
Snowflake Description

Good value with adequate balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
CPL
DB
MX$3B
Market Cap
  1. Home
  2. DE
  3. Consumer Durables
Company description

Corpovael, S.A.B. de C.V. engages in the design, urbanization, building, promotion, and sale of homes. The last earnings update was 21 days ago. More info.


Add to Portfolio Compare Print
CPL Share Price and Events
7 Day Returns
0%
DB:CPL
-1.1%
DE Consumer Durables
0.1%
DE Market
1 Year Returns
-8.9%
DB:CPL
2.9%
DE Consumer Durables
8.8%
DE Market
CPL Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Corpovael. de (CPL) 0% 0% -8.7% -8.9% -19.3% -
DE Consumer Durables -1.1% 3.5% 4.1% 2.9% -5.9% 11.6%
DE Market 0.1% 5.9% 15% 8.8% 14.5% 21%
1 Year Return vs Industry and Market
  • CPL underperformed the Consumer Durables industry which returned 2.9% over the past year.
  • CPL underperformed the Market in Germany which returned 8.8% over the past year.
Price Volatility
CPL
Industry
5yr Volatility vs Market
Related Companies

Sorry, no analysis for Corpovael. de's competitors could be found in our database.

Value

 Is Corpovael. de undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Corpovael. de to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Corpovael. de.

DB:CPL Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model Dividend Discount Model
Dividend Per Share Company Filings (2019-09-30) in MXN MX$ .850000
Payout Ratio Company Filings (2019-09-30) 3243.3%
Discount Rate (Cost of Equity) See below 6.4%
Perpetual Growth Rate 10-Year DE Government Bond Rate 0.2%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for DB:CPL
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate 0.2%
Equity Risk Premium S&P Global 6%
Consumer Durables Unlevered Beta Simply Wall St/ S&P Global 0.81
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.815 (1 + (1- 30%) (121.07%))
1.039
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
1.04
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 0.23% + (1.039 * 5.96%)
6.42%

Discounted Cash Flow Calculation for DB:CPL using Dividend Discount Model Model

The calculations below outline how an intrinsic value for Corpovael. de is arrived at by discounting future dividends to their present value. This approach is used for finance firms where free cash flow is difficult to estimate (e.g. Banks/ Insurance firms).

If the firm does not pay the majority of its earnings out as a dividend this method will often arrive at a value significantly lower than the share price.

See our documentation to learn about this calculation.

DB:CPL Gordon Growth Model
Calculation Result
Value per share = Expected dividends per share / (Discount Rate - Perpetual growth rate)
= MX$0.85 / (6.42% - 0.23%)
MX$0.05
DB:CPL Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in DB:CPL represents 0.06208x of BMV:CADU A
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.06208x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (MXN) x Listing Adjustment Factor
= MX$ 13.72 x 0.06208
€0.85
Value per share (EUR) From above. €0.85
Current discount Discount to share price of €0.56
= -1 x (€0.56 - €0.85) / €0.85
34.8%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Corpovael. de is available for.
Intrinsic value
35%
Share price is €0.555 vs Future cash flow value of €0.85175
Current Discount Checks
For Corpovael. de to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Corpovael. de's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Corpovael. de's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Corpovael. de's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Corpovael. de's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:CPL PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in MXN MX$2.37
BMV:CADU A Share Price ** BMV (2019-10-15) in MXN MX$8.94
Germany Consumer Durables Industry PE Ratio Median Figure of 8 Publicly-Listed Consumer Durables Companies 17.05x
Germany Market PE Ratio Median Figure of 402 Publicly-Listed Companies 19.83x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Corpovael. de.

DB:CPL PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= BMV:CADU A Share Price ÷ EPS (both in MXN)

= 8.94 ÷ 2.37

3.76x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Corpovael. de is good value based on earnings compared to the DE Consumer Durables industry average.
  • Corpovael. de is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Corpovael. de's expected growth come at a high price?
Raw Data
DB:CPL PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 3.76x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
2.9%per year
Germany Consumer Durables Industry PEG Ratio Median Figure of 5 Publicly-Listed Consumer Durables Companies 0.97x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.36x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Corpovael. de, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Corpovael. de's assets?
Raw Data
DB:CPL PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in MXN MX$13.94
BMV:CADU A Share Price * BMV (2019-10-15) in MXN MX$8.94
Germany Consumer Durables Industry PB Ratio Median Figure of 12 Publicly-Listed Consumer Durables Companies 1.69x
Germany Market PB Ratio Median Figure of 577 Publicly-Listed Companies 1.83x
DB:CPL PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= BMV:CADU A Share Price ÷ Book Value per Share (both in MXN)

= 8.94 ÷ 13.94

0.64x

* Primary Listing of Corpovael. de.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Corpovael. de is good value based on assets compared to the DE Consumer Durables industry average.
X
Value checks
We assess Corpovael. de's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Consumer Durables industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Consumer Durables industry average (and greater than 0)? (1 check)
  5. Corpovael. de has a total score of 4/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Corpovael. de expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

  • No analysts cover Corpovael. de, future earnings growth has been estimated based on fundamentals.
The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
2.9%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Corpovael. de expected to grow at an attractive rate?
  • Corpovael. de's earnings growth is expected to exceed the low risk savings rate of 0.2%.
Growth vs Market Checks
  • Corpovael. de's earnings growth is positive but not above the Germany market average.
  • Unable to compare Corpovael. de's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:CPL Future Growth Rates Data Sources
Data Point Source Value (per year)
DB:CPL Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts 2.9%
Germany Consumer Durables Industry Earnings Growth Rate Market Cap Weighted Average 15%
Germany Consumer Durables Industry Revenue Growth Rate Market Cap Weighted Average 4.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 12.7%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.9%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:CPL Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in MXN Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:CPL Future Estimates Data
Date (Data in MXN Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2019-11-14
DB:CPL Past Financials Data
Date (Data in MXN Millions) Revenue Cash Flow Net Income *
2019-09-30 4,630 -181 814
2019-06-30 4,797 -318 837
2019-03-31 4,869 -362 843
2018-12-31 4,626 -161 778
2018-09-30 4,793 -6 785
2018-06-30 4,746 211 757
2018-03-31 4,595 539 724
2017-12-31 4,507 201 711
2017-09-30 4,145 60 620
2017-06-30 3,873 -279 564
2017-03-31 3,761 -631 557
2016-12-31 4,022 -617 581

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Corpovael. de's earnings are expected to grow by 2.9% yearly, however this is not considered high growth (20% yearly).
  • Unable to determine if Corpovael. de is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:CPL Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Corpovael. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:CPL Future Estimates Data
Date (Data in MXN Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2019-11-14
DB:CPL Past Financials Data
Date (Data in MXN Millions) EPS *
2019-09-30 2.37
2019-06-30 2.44
2019-03-31 2.47
2018-12-31 2.28
2018-09-30 2.30
2018-06-30 2.22
2018-03-31 2.12
2017-12-31 2.08
2017-09-30 1.84
2017-06-30 1.66
2017-03-31 1.62
2016-12-31 1.70

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Corpovael. de will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Corpovael. de's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Corpovael. de has a total score of 1/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Corpovael. de performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Corpovael. de's growth in the last year to its industry (Consumer Durables).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Corpovael. de's year on year earnings growth rate has been positive over the past 5 years.
  • Corpovael. de's 1-year earnings growth is less than its 5-year average (3.7% vs 19.1%)
  • Corpovael. de's earnings growth has exceeded the DE Consumer Durables industry average in the past year (3.7% vs -21.1%).
Earnings and Revenue History
Corpovael. de's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Corpovael. de Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:CPL Past Revenue, Cash Flow and Net Income Data
Date (Data in MXN Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 4,630.35 814.30 581.49
2019-06-30 4,797.19 837.01 574.76
2019-03-31 4,869.32 842.58 549.03
2018-12-31 4,625.57 778.25 521.39
2018-09-30 4,793.18 785.35 485.50
2018-06-30 4,745.96 757.06 472.40
2018-03-31 4,594.98 723.52 443.12
2017-12-31 4,507.21 710.98 446.69
2017-09-30 4,145.24 620.44 428.99
2017-06-30 3,872.62 564.17 407.20
2017-03-31 3,761.37 556.84 394.42
2016-12-31 4,021.67 581.36 387.89
2016-09-30 3,764.38 541.80 345.89
2016-06-30 3,611.82 516.76 335.10
2016-03-31 3,549.82 461.04 332.85
2015-12-31 3,523.02 428.01 331.26
2015-09-30 3,891.15 459.37 343.07
2015-06-30 3,992.05 452.87 340.51
2015-03-31 3,619.48 401.54 310.58
2014-12-31 3,189.49 333.80 291.87
2014-09-30 2,792.68 221.46 271.91
2014-06-30 2,613.50 199.41 271.74
2014-03-31 2,538.88 222.25 280.07
2013-12-31 2,607.70 290.87 270.74
2013-09-30 2,418.26 329.87 251.26
2013-06-30 2,150.95 316.06 212.96
2013-03-31 1,974.56 278.68 183.08
2012-12-31 1,907.82 278.96 168.14

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Corpovael. de has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Corpovael. de used its assets more efficiently than the DE Consumer Durables industry average last year based on Return on Assets.
  • Corpovael. de's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Corpovael. de's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Consumer Durables industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Corpovael. de has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Corpovael. de's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Corpovael. de's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Corpovael. de is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Corpovael. de's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Corpovael. de's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 2.5x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Corpovael. de Company Filings, last reported 1 month ago.

DB:CPL Past Debt and Equity Data
Date (Data in MXN Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 4,903.95 3,701.91 898.85
2019-06-30 4,723.89 3,709.08 1,060.44
2019-03-31 4,786.25 3,656.46 1,495.46
2018-12-31 4,609.20 3,370.81 674.38
2018-09-30 4,364.96 3,171.06 1,082.61
2018-06-30 4,124.82 2,833.73 1,070.63
2018-03-31 4,146.19 2,737.88 1,161.16
2017-12-31 4,039.15 2,319.43 607.67
2017-09-30 3,788.62 2,308.47 721.70
2017-06-30 3,582.59 2,187.06 634.27
2017-03-31 3,609.64 2,329.79 673.98
2016-12-31 3,520.56 1,982.36 593.78
2016-09-30 3,381.21 1,933.38 647.84
2016-06-30 3,272.71 1,730.94 771.87
2016-03-31 3,333.42 1,525.80 1,034.54
2015-12-31 3,224.92 1,608.60 1,233.23
2015-09-30 1,510.56 2,057.05 261.80
2015-06-30 1,394.64 1,835.78 395.90
2015-03-31 1,369.16 1,655.30 218.01
2014-12-31 1,288.03 1,511.57 282.17
2014-09-30 1,150.16 1,459.84 160.32
2014-06-30 1,138.94 1,316.28 175.13
2014-03-31 1,063.27 1,256.23 245.96
2013-12-31 1,049.13 1,123.60 157.79
2013-09-30 1,138.80 1,140.54 221.38
2013-06-30 1,138.93 1,198.58 172.19
2013-03-31 1,054.56 1,130.42 89.50
2012-12-31 969.32 913.16 105.62
  • Corpovael. de's level of debt (75.5%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (126.8% vs 75.5% today).
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 73.3x coverage).
X
Financial health checks
We assess Corpovael. de's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Corpovael. de has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Corpovael. de's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
9.51%
Current annual income from Corpovael. de dividends.
If you bought €2,000 of Corpovael. de shares you are expected to receive €190 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Corpovael. de's pays a higher dividend yield than the bottom 25% of dividend payers in Germany (1.38%).
  • Corpovael. de's dividend is above the markets top 25% of dividend payers in Germany (3.68%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:CPL Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Consumer Durables Industry Average Dividend Yield Market Cap Weighted Average of 6 Stocks 3.1%
Germany Market Average Dividend Yield Market Cap Weighted Average of 334 Stocks 2.9%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.7%
Germany Bottom 25% Dividend Yield 25th Percentile 1.4%
Germany Top 25% Dividend Yield 75th Percentile 3.7%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

DB:CPL Future Dividends Estimate Data
Date (Data in MX$) Dividend per Share (annual) Avg. No. Analysts
2019-11-14
DB:CPL Past Annualized Dividends Data
Date (Data in MX$) Dividend per share (annual) Avg. Yield (%)
2019-07-22 0.850 7.405
2019-05-28 0.850 5.894
2019-05-21 0.850 5.898
2018-04-25 0.750 5.095
2017-07-18 0.660 5.178
2017-04-25 0.660 6.414
2017-02-21 0.660 7.280
2016-04-18 0.660 4.709

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Whilst dividend payments have been stable, Corpovael. de has been paying a dividend for less than 10 years.
  • Dividend payments have increased, but Corpovael. de only paid a dividend in the past 4 years.
Current Payout to shareholders
What portion of Corpovael. de's earnings are paid to the shareholders as a dividend.
  • Dividends paid are well covered by earnings (2.8x coverage).
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Corpovael. de's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.7%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Corpovael. de afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Corpovael. de has a total score of 3/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Corpovael. de's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
  • Corpovael. de has no CEO, or we have no data on them.
Management Team

Joaquin Vaca Elguero

TITLE
Secretary of the Board & Equity Director
Board of Directors

Pedro Vaca Elguero

TITLE
Chairman of The Board

Joaquin Vaca Elguero

TITLE
Secretary of the Board & Equity Director

Luis Vaca Elguero

TITLE
Related Patrimonial Director

Pablo Vaca Elguero

TITLE
Equity Director

Alberto Mulas Rincon

TITLE
Independent Director
TENURE
12.8 yrs

Manuel Francisco Arce Rincón

TITLE
Independent Director
AGE
78
TENURE
10.8 yrs

Javier Cervantes Monteil

TITLE
Related Director
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
X
Management checks
We assess Corpovael. de's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Corpovael. de has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Corpovael, S.A.B. de C.V. engages in the design, urbanization, building, promotion, and sale of homes. The company was founded in 2001 and is based in Cancun, Mexico.

Details
Name: Corpovael, S.A.B. de C.V.
CPL
Exchange: DB
Founded: 2001
MX$142,908,527
342,022,974
Website: http://www.caduinmobiliaria.com
Address: Corpovael, S.A.B. de C.V.
Primer Piso,
Av. Bonampak, Smz. 6, Mz. 1, Lt. 1,
Cancun,
Quintana Roo, 77500,
Mexico
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
BMV CADU A Series A Fixed Shares Bolsa Mexicana de Valores MX MXN 04. Dec 2015
OTCPK CRPV.F Series A Fixed Shares Pink Sheets LLC US USD 04. Dec 2015
DB CPL Series A Fixed Shares Deutsche Boerse AG DE EUR 04. Dec 2015
Number of employees
Current staff
Staff numbers
10
Corpovael. de employees.
Industry
Homebuilding
Consumer Durables
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/14 21:58
End of day share price update: 2019/10/15 00:00
Last estimates confirmation: 2019/10/22
Last earnings filing: 2019/10/24
Last earnings reported: 2019/09/30
Last annual earnings reported: 2018/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.